EP 3675863 A1 20200708 - PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOF
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOF
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT SEPIAPTERIN UND VERWENDUNGEN DAVON
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA SÉPIAPTÉRINE ET SES UTILISATIONS
Publication
Application
Priority
- US 201762553603 P 20170901
- US 201862678069 P 20180530
- US 2018049359 W 20180904
Abstract (en)
[origin: WO2019046849A1] The present invention features pharmaceutical compositions including sepiapterin, or a pharmaceutically acceptable salt and/or co-crystal thereof, and methods for the treatment of tetrahydrobiopterin-related disorders (e.g., tetrahydrobiopterin deficiency or phenylketonuria) with such compositions.
IPC 8 full level
A61K 31/519 (2006.01); A61K 9/20 (2006.01)
CPC (source: EP US)
A61K 9/0095 (2013.01 - EP); A61K 9/14 (2013.01 - US); A61K 9/20 (2013.01 - US); A61K 31/519 (2013.01 - EP US); A61K 38/40 (2013.01 - US); A61K 47/22 (2013.01 - EP); A61K 47/38 (2013.01 - EP); A61P 3/00 (2018.01 - EP); A61P 25/00 (2018.01 - US); A61K 9/1617 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019046849 A1 20190307; BR 112020003865 A2 20200908; BR 112020003865 A8 20220816; CA 3073957 A1 20190307; CN 111491635 A 20200804; EP 3675863 A1 20200708; EP 3675863 A4 20210127; JP 2020532535 A 20201112; JP 2023116556 A 20230822; MX 2020002271 A 20201005; US 11752154 B2 20230912; US 2020061070 A1 20200227; US 2024100054 A1 20240328
DOCDB simple family (application)
US 2018049359 W 20180904; BR 112020003865 A 20180904; CA 3073957 A 20180904; CN 201880070952 A 20180904; EP 18850633 A 20180904; JP 2020512443 A 20180904; JP 2023088749 A 20230530; MX 2020002271 A 20180904; US 201916670362 A 20191031; US 202318235486 A 20230818